Analytical Data
-
Gene name
COL14
- Application
-
Alternative Names
COL14A1; COL14-A1; UND; undulin; Collagen Type XIV Alpha 1
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q05707
-
Expression Region
Glu1280~Leu1461
-
Molecular Weight
50kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
COL14, or collagen type XIV, is a member of the collagen family that plays a crucial role in the structural integrity and organization of extracellular matrices (ECMs). It is predominantly found in various tissues, including skin, cartilage, and tendons, where it assists in cell adhesion, proliferation, and differentiation. Research has shown that COL14 interacts with other ECM proteins and influences key biological processes such as wound healing, tissue repair, and development. Dysregulation of COL14 expression has been implicated in numerous diseases, including fibrosis and cancer, making it a subject of interest in regenerative medicine and pathology. The recombinant expression of COL14 protein allows for in-depth functional studies and offers potential therapeutic applications, such as tissue engineering and the development of biomaterials. By understanding COL14's mechanisms, researchers aim to leverage its properties to innovate treatments for various conditions that involve ECM remodeling or structural impairments. As such, COL14 represents a promising target for future research endeavors in cell biology, tissue engineering, and targeted therapies.
